Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IB Study of QRH-882260 Heptapeptide Application in the Colon

NCT03148119 is registered in ClinicalTrials.gov with Danielle Kim Turgeon as lead sponsor.

NCT NCT03148119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03148119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IB Study of QRH-882260 Heptapeptide Application in the Colon
Lead sponsor
Danielle Kim Turgeon
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2017
Completion date
July 11, 2017
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer prevention